Home » Echo Therapeutics Completes Product Development of Prelude SkinPrep System
Echo Therapeutics Completes Product Development of Prelude SkinPrep System
Echo Therapeutics, Inc., a company developing the needle-free
Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal
drug delivery, announced Monday that the Company has completed the product development work for its Prelude SkinPrep System and now has the commercially
ready product to be used in final clinical trials.
Sun Herald
Sun Herald
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May